You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult primary cholangiocellular carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +39 more
  • Chicago, Illinois
  • +1 more
May 7, 2020

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +6 more
  • PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 21, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary

    Suspended
    • Adult Primary Hepatocellular Carcinoma
    • +3 more
    • sorafenib tosylate
    • +2 more
    • Birmingham, Alabama
    • +20 more
    Aug 29, 2022

    Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

    Recruiting
    • Refractory Cancer
    • +14 more
    • Atlanta, Georgia
    • +1 more
    Oct 23, 2023

    Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Fairfax, Virginia
      NEXT Oncology
    Jun 7, 2023

    Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

    Recruiting
    • Pulmonary Neuroendocrine Neoplasm
    • +9 more
    • Houston, Texas
      Excel Diagnostics and Nuclear Oncology Center
    Jul 9, 2021

    Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

    Recruiting
    • Adult Primary Liver Cancer
    • +2 more
    • TSR-022 and TSR-042
    • Honolulu, Hawaii
      University of Hawaii
    Sep 22, 2021

    Advanced Solid Tumor, Non-small Cell Carcinoma, Pancreatic Cancer Trial in Beijing, Chongqing, Zhejiang (GH21 Capsule)

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • GH21 Capsule
    • Beijing, Beijing, China
    • +2 more
    Feb 9, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Duarte, California
    • +7 more
    Sep 26, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • Bengbu, Anhui, China
    • +27 more
    Nov 14, 2022

    Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

    Recruiting
    • Lung Cancer
    • +5 more
    • Stereotactic Radiosurgery
    • Cerebrospinal fluid collection
    • Basking Ridge, New Jersey
    • +6 more
    Nov 11, 2022

    Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)

    Recruiting
    • Cholangiocarcinoma
    • Combination of Lonsurf® and Irinotecan
    • Düsseldorf, NRW, Germany
      Klinik für Gastroenterologie, Hepatologie und Infektiologie
    Dec 22, 2022

    NRG1, NRG1 Fusion, Pancreatic Cancer Trial (MCLA-128)

    Available
    • NRG1
    • +11 more
    • (no location specified)
    Jul 21, 2021

    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in

    Completed
    • Adult Primary Hepatocellular Carcinoma
    • +4 more
    • Chinese herbal formulation PHY906
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jan 26, 2021

    Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,

    Recruiting
    • Recurrent Ovarian Cancer
    • +2 more
    • Birmingham, Alabama
    • +14 more
    Oct 11, 2022

    Liver Cancer, Liver Cirrhosis Trial in Basel (Radioactive Seed Implantation)

    Completed
    • Liver Cancer
    • Liver Cirrhosis
    • Radioactive Seed Implantation
    • Basel, Switzerland
      University hospital
    Aug 9, 2023

    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

    Recruiting
    • Adult Primary Hepatocellular Carcinoma
    • +3 more
    • yttrium Y 90 glass microspheres
    • laboratory biomarker analysis
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Sep 17, 2020

    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in

    Active, not recruiting
    • Adult Primary Hepatocellular Carcinoma
    • +2 more
    • sorafenib tosylate
    • stereotactic body radiation therapy
    • Berkeley, California
    • +50 more
    Nov 17, 2022

    Use of Cemiplimab in Adult Patients in UK

    Active, not recruiting
    • Cutaneous Squamous Cell Carcinoma
    • No intervention
    • Reading, Berkshire, United Kingdom
      Sanofi-Aventis UK
    Aug 7, 2022

    Liver Cancer Trial (gemcitabine HCl, lonafarnib, conventional surgery)

    Withdrawn
    • Liver Cancer
    • gemcitabine hydrochloride
    • +2 more
    • (no location specified)
    Jul 29, 2020

    Superficial Basal Cell Carcinoma Trial (Tirbanibulin Ointment 1%)

    Not yet recruiting
    • Superficial Basal Cell Carcinoma
    • Tirbanibulin Ointment 1%
    • (no location specified)
    Jan 27, 2023

    Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

    Not yet recruiting
    • Non-melanoma Skin Cancer
    • +3 more
    • Calgary, Alberta, Canada
    • +7 more
    Jul 13, 2023